Literature DB >> 760732

Bioavailability of chlorpropamide.

M Evans, R C Glass, M Mitchard, B M Munday, R Yates.   

Abstract

1. The serum profiles of chlorpropamide obtained following single doses of two tablet preparations and from a suspension formulation have been compared in healthy volunteers. The amounts of chlorpropamide absorbed from the three formulations were similar but the drug was absorbed more rapidly from the suspension than from either tablet formulation. There was a small but therapeutically insignificant difference in the rate of absorption of the drug from the two tablets. 2. Changes in blood glucose concentrations were found to be related to the drug serum profile characteristics of the formulations.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 760732      PMCID: PMC1429599          DOI: 10.1111/j.1365-2125.1979.tb00904.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  8 in total

1.  Plasma concentrations, bioavailability and dissolution of chlorpropamide.

Authors:  T Taylor; D F Assinder; L F Chasseaud; P M Bradford; J S Burton
Journal:  Eur J Clin Pharmacol       Date:  1977-03-11       Impact factor: 2.953

2.  Metabolism and relative hypoglycemic potencies of four sulfonylureas in man.

Authors:  K M WEST; P C JOHNSON
Journal:  Diabetes       Date:  1960 Nov-Dec       Impact factor: 9.461

3.  The correlation between oral dosage, blood levels, and clinical and metabolic activity of chlorpropamide in the treatment of diabetes mellitus.

Authors:  S B BEASER
Journal:  Ann N Y Acad Sci       Date:  1959-03-30       Impact factor: 5.691

4.  Metabolic studies of chlorpropamide in normal men and in diabetic subjects.

Authors:  R E KNAUFF; S S FAJANS; E RAMIREZ; J W CONN
Journal:  Ann N Y Acad Sci       Date:  1959-03-30       Impact factor: 5.691

5.  A laboratory and clinical study of chlorpropamide in ambulatory diabetics.

Authors:  M B HANDELSMAN; L LEVITT; M F CALABRETTA
Journal:  Ann N Y Acad Sci       Date:  1959-03-30       Impact factor: 5.691

6.  Blood levels of chlorpropamide in normal men following chronic administration.

Authors:  M CARLOZZI; D G IEZZONI; L SILVER
Journal:  Ann N Y Acad Sci       Date:  1959-03-30       Impact factor: 5.691

7.  The bioavailability in man of marketed brands of chlorpropamide.

Authors:  A M Monro; P G Welling
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

8.  Pharmacokinetics and biotransformation of chlorpropamide in man.

Authors:  J A Taylor
Journal:  Clin Pharmacol Ther       Date:  1972 Sep-Oct       Impact factor: 6.875

  8 in total
  2 in total

Review 1.  Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.

Authors:  J E Jackson; R Bressler
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

Review 2.  Clinical pharmacokinetics of sulphonylurea hypoglycaemic drugs.

Authors:  L Balant
Journal:  Clin Pharmacokinet       Date:  1981 May-Jun       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.